Helen Sabzevari

CIK 1724195 · President and CEO · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.77M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$4.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PGEN President and CEO 3,768,872 $4.45 $16.77M -$4.49M 35 2026-06-01
Kinnate Biopharma Inc. (KNTE) Delisted Director $2.65 $0 3 2023-06-13
PRECIGEN, INC. (XON) Delisted President and CEO 104,734 -$366.3K 13 2020-01-07

Recent Filings · Page 3 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-30 PGEN Buy (P) +22,857 $40.0K EDGAR
2023-01-06 PGEN Exer (M) +17,665 $0 EDGAR
2022-06-15 Kinnate Biopharma Inc. (KNTE) Delisted Grant (A) $0 EDGAR
2022-05-16 PGEN Mixed +162,941 -$210.9K EDGAR
2022-03-22 PGEN Grant (A) $0 EDGAR
2022-02-04 PGEN Grant (A) $0 EDGAR
2022-01-06 PGEN Mixed +10,707 -$25.0K EDGAR
2022-01-04 PGEN Mixed +5,917 -$14.1K EDGAR
2021-07-20 PGEN Mixed +12,469 -$68.0K EDGAR
2021-06-28 Kinnate Biopharma Inc. (KNTE) Delisted Grant (A) $0 EDGAR
Showing 2130 of 52
Page 3 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.